Literature DB >> 22235851

EZH2 mutations and their association with PICALM-MLLT10 positive acute leukaemia.

Vera Grossmann, Ulrike Bacher, Alexander Kohlmann, Valentina Artusi, Hans-Ulrich Klein, Martin Dugas, Susanne Schnittger, Tamara Alpermann, Wolfgang Kern, Torsten Haferlach, Claudia Haferlach.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22235851     DOI： 10.1111/j.1365-2141.2011.08986.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  8 in total

1.  The prognosis of CALM-AF10-positive adult T-cell acute lymphoblastic leukemias depends on the stage of maturation arrest.

Authors:  Raouf Ben Abdelali; Vahid Asnafi; Arnaud Petit; Jean-Baptiste Micol; Céline Callens; Patrick Villarese; Eric Delabesse; Oumedaly Reman; Stephane Lepretre; Jean-Yves Cahn; Gaelle Guillerm; Céline Berthon; Claude Gardin; Bernadette Corront; Thibaut Leguay; Marie-Christine Béné; Norbert Ifrah; Guy Leverger; Hervé Dombret; Elizabeth Macintyre
Journal:  Haematologica       Date:  2013-07-05       Impact factor: 9.941

2.  Gene expression profiling and candidate gene resequencing identifies pathways and mutations important for malignant transformation caused by leukemogenic fusion genes.

Authors:  Rachel L Novak; David P Harper; David Caudell; Christopher Slape; Sarah H Beachy; Peter D Aplan
Journal:  Exp Hematol       Date:  2012-08-08       Impact factor: 3.084

3.  Site- and allele-specific polycomb dysregulation in T-cell leukaemia.

Authors:  Jean-Marc Navarro; Aurore Touzart; Lydie C Pradel; Marie Loosveld; Myriam Koubi; Romain Fenouil; Sandrine Le Noir; Muhammad Ahmad Maqbool; Ester Morgado; Claude Gregoire; Sebastien Jaeger; Emilie Mamessier; Charles Pignon; Salima Hacein-Bey-Abina; Bernard Malissen; Marta Gut; Ivo G Gut; Hervé Dombret; Elizabeth A Macintyre; Steven J Howe; H Bobby Gaspar; Adrian J Thrasher; Norbert Ifrah; Dominique Payet-Bornet; Estelle Duprez; Jean-Christophe Andrau; Vahid Asnafi; Bertrand Nadel
Journal:  Nat Commun       Date:  2015-01-23       Impact factor: 14.919

4.  Weaver Syndrome-Associated EZH2 Protein Variants Show Impaired Histone Methyltransferase Function In Vitro.

Authors:  Ana S A Cohen; Damian B Yap; M E Suzanne Lewis; Chieko Chijiwa; Maria A Ramos-Arroyo; Natália Tkachenko; Valentina Milano; Mélanie Fradin; Margaret L McKinnon; Katelin N Townsend; Jieqing Xu; M I Van Allen; Colin J D Ross; William B Dobyns; David D Weaver; William T Gibson
Journal:  Hum Mutat       Date:  2016-01-12       Impact factor: 4.878

5.  Ezh2 Controls an Early Hematopoietic Program and Growth and Survival Signaling in Early T Cell Precursor Acute Lymphoblastic Leukemia.

Authors:  Etienne Danis; Taylor Yamauchi; Kristen Echanique; Xi Zhang; Jessica N Haladyna; Simone S Riedel; Nan Zhu; Huafeng Xie; Stuart H Orkin; Scott A Armstrong; Kathrin M Bernt; Tobias Neff
Journal:  Cell Rep       Date:  2016-02-18       Impact factor: 9.423

6.  Loss of quiescence and self-renewal capacity of hematopoietic stem cell in an in vitro leukemic niche.

Authors:  Natalia-Del Pilar Vanegas; Jean-Paul Vernot
Journal:  Exp Hematol Oncol       Date:  2017-01-10

7.  Large-scale gene network analysis reveals the significance of extracellular matrix pathway and homeobox genes in acute myeloid leukemia: an introduction to the Pigengene package and its applications.

Authors:  Amir Foroushani; Rupesh Agrahari; Roderick Docking; Linda Chang; Gerben Duns; Monika Hudoba; Aly Karsan; Habil Zare
Journal:  BMC Med Genomics       Date:  2017-03-16       Impact factor: 3.063

8.  Mutations in EZH2 are associated with poor prognosis for patients with myeloid neoplasms.

Authors:  Qi Zhang; Qi Han; Jie Zi; Jinlong Ma; Huihui Song; Yulu Tian; Mary McGrath; Chunhua Song; Zheng Ge
Journal:  Genes Dis       Date:  2019-05-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.